InternationalUSRemember you can easily switch between MIP US and MIP International at any time

European Patent Reform Forum 2014: AGENDA - MUNICH




Agenda-Munich

Agenda- Paris

Speakers - Munich

Speakers - Paris

delegates Munich

Delegates - Paris



Contact us

Download the Munich agenda

8.00 Registration

8.45 Opening remarks by Managing IP

8.50 The Unified Patent Court explained in detail

  • How to best navigate the new divisions and structures
  • A practical guide to making best use of the courts and mitigating costs
  • Understanding procedures: From starting proceedings through to trial
  • Strategising in advance
Tim Powell, partner, Powell Gilbert
Christine Kanz, partner, ROKH IP
Pierre Véron
, partner, Véron & Associés

9.45 Split Proceedings and the UPC

  • Complaints by Licensees, Counterclaims for Revocation against Proprietor
  • Bifurcation: Debunking the myths - Evaluating the possible pros and cons
  • Appeals against Bifurcation under the 16th draft of the Rules of Procedure
  • What should be learnt from current German practice?
  • How judges will handle bifurcation
Jochen Meyer, head of IPR Germany, Vodafone
Joachim Feldges,
partner, Allen & Overy
David Por,
partner, Allen & Overy

10.40 Coffee break and networking

    11.00 The European Court of Justice and the Unified Patent Court

    • How the Spanish challenge affected plans for the new system
    • When will/ won't the ECJ be able to review issues of law pertaining to patents?
    David Rose, partner, King & Wood Mallesons SJ Berwin
    Axel Walz,
    partner, King & Wood Mallesons SJ Berwin

    11.55 Swiss focus

    • The new patent court – how does it work?
    • Implications of the new patent court, and how it interacts with the UPC
    • Challenges and opportunities for companies doing business in Switzerland
    Simon Holzer, partner, meyerlustenberger | lachenal
    Michael Ritscher,
    partner, meyerlustenberger | lachenal

    12.25 Lunch and networking

      13.15 The Unitary Patent

      • Pros and cons of filing the UP in comparison to a national patent
      • Strategic advice for prosecution
      • A guide to the translation regime
      • An overview of costs
      Eskil Waage, lawyer, international legal affairs, European Patent Office
      Michael Schneider,
      partner, Wragge Lawrence Graham & Co
      David Barron,
      partner, Wragge Lawrence Graham & Co

      14.10 Alternative IP strategies parallel to the UPC

      • Avoiding the down-sides of court litigation before the UPC: Alternative dispute resolution and arbitration proceedings
      • Best practices and strategies to utilize third party observations and opposition proceedings before the EPO
      • Interdependency and future interplay between existing legal mechanisms and the UPC-system
      Simon Roberts, director of patents, BT
      Jürgen Schneider,
      vice president, global IP & IP litigation, QIAGEN
      Clemens Plassmann,
      partner, Hogan Lovells
      Steffen Steininger,
      partner, Hogan Lovells

      15.05 Coffee break and networking

        15.25 Litigation planning and forum shopping in the European Unified Patent Court

        • Game over? Litigation planning and strategy under the new UPC
        • Risks and opportunities of forum shopping in Europe
        Penny Gilbert, partner, Powell Gilbert
        Kay Kasper,
        partner, ROKH IP
        Thomas Bouvet
        , partner, Véron & Associés

        16.20 Inter-industry debate - International litigation considerations

        • How different countries regard the UPC
        • The future of national legislation
        • The unanswered questions about the UPC
        Michael Fröhlich, senior director, EU intellectual property & strategy, Blackberry
        Clemens Heusch,
        head of European litigation, Nokia
        Alex Wilson,
        partner, Powell Gilbert
        Tobias Hahn,
        partner, ROKH IP
        Sabine Age
        , partner, Véron & Associés

        17.15 End of conference

           


        Lead Sponsors

             ROKH IP      Vernon & Associes

        Sponsors

             Grunecker

        Hogan Lovells      King & Wood Mallesons SJ Berwin      Meyerlustenberger Lachenal


        Ropes & Gray     


        Association Partner

        EPO      GRUR      GRUR

        Media Partner

        Patent Lawyer
        profile

        Managing IP

        ManagingIP

        ManagingIP profile

        "Call it something with the word Virgin" maybe??? https://t.co/X7J2iiMYtZ

        Mar 29 2017 04:57 ·  reply ·  retweet ·  favourite
        ManagingIP profile

        RT @HouseJudiciary: ✅ #BREAKING: @HouseJudiciary approves #HR1695- Register of Copyrights Selection & Accountability Act. 1st step to moder…

        Mar 29 2017 04:37 ·  reply ·  retweet ·  favourite
        ManagingIP profile

        SCOTUS revisits patent venue in TC Heartland v Kraft arguments - analysis https://t.co/u8u7RmhQ7J https://t.co/bqESUSa7Vq

        Mar 29 2017 04:36 ·  reply ·  retweet ·  favourite
        More from the Managing IP blog


        March 2017

        Roundtable: The second medical use challenge – full transcript

        Three leading patent specialists discussed one of the most challenging issues in IP at the moment – incentivising new uses for known drugs – at a recent roundtable discussion. The participants were: Jurgen Dressel, head of global patent litigation strategy, Novartis Pharma; Galit Gonen, VP and general counsel for Europe at Teva; and Professor Sir Robin Jacob, former Court of Appeal judge and professor at the Institute of Brand and Innovation Law, University College London



        Most read articles

        Supplements